Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Ani Pharmaceuticals (ANIP) Receivables - Net (2016 - 2026)

Ani Pharmaceuticals' Receivables - Net history spans 14 years, with the latest figure at $281.1 million for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 26.77% to $281.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $281.1 million, a 26.77% increase, with the full-year FY2025 number at $281.1 million, up 26.77% from a year prior.
  • Receivables - Net hit $281.1 million in Q4 2025 for Ani Pharmaceuticals, up from $252.6 million in the prior quarter.
  • Over the last five years, Receivables - Net for ANIP hit a ceiling of $281.1 million in Q4 2025 and a floor of $91.9 million in Q1 2021.
  • Historically, Receivables - Net has averaged $171.6 million across 5 years, with a median of $169.3 million in 2024.
  • Biggest five-year swings in Receivables - Net: surged 62.35% in 2022 and later decreased 3.95% in 2024.
  • Tracing ANIP's Receivables - Net over 5 years: stood at $128.5 million in 2021, then rose by 28.72% to $165.4 million in 2022, then decreased by 2.03% to $162.1 million in 2023, then soared by 36.8% to $221.7 million in 2024, then increased by 26.77% to $281.1 million in 2025.
  • Business Quant data shows Receivables - Net for ANIP at $281.1 million in Q4 2025, $252.6 million in Q3 2025, and $225.7 million in Q2 2025.